A Phase 2 Study to Assess the Efficacy and Safety of Cannabidiol Oral Solution for the Treatment of Refractory Infantile Spasms
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 03 Aug 2017
At a glance
- Drugs Cannabidiol (Primary)
- Indications Infantile spasms
- Focus Therapeutic Use
- Sponsors INSYS Therapeutics, Inc
- 31 Jul 2017 Planned End Date changed from 1 Jul 2017 to 1 Aug 2017.
- 31 Jul 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Aug 2017.
- 01 Sep 2016 Status changed from recruiting to active, no longer recruiting.